In this section of the site you can easily access information on the Clinical Studies sponsored by the Menarini Group. Those that are either on-going or recruiting patients are in the “Clinical Trial Registry” section, those that have already been completed casn be found in the “Clinical Trial Results” section.

The Menarini Group adheres to the principles set forth in the “JOINT POSITION ON THE DISCLOSURE OF CLINICAL TRIAL INFORMATION VIA CLINICAL TRIAL REGISTRIES AND DATABASES”. This represents the position agreed upon by the international pharmaceutical associations EFPIA (European Federation of Pharmaceutical Industries and Associations), IFPMA (International Federation of Pharmaceutical Manufacturers and Associations), JPMA (Japanese Pharmaceutical Manufacturers Association) and PhRMA (Pharmaceutical Research and Manufacturers of America). The aim is to make information on Clinical Trials readily and easily accessible, in the context of transparency in Clinical Research by the Industry, with the commitment to providing patients and health personnel with all the relevant information on newly developed products.

The use of the medicinal products as it emerges from the data reported in this section may not be entirely in line with the indications currently approved by the competent regulatory authorities. The information given herein is not meant as medical promotion, nor is it meant to replace the advice of the physician, who is ultimately responsible for the choice of the most suitable treatment for the individual patient.